Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Retrosi, C; Vezzoni, R; Conforti, C; Corneli, P; Magaton-Rizzi, G; Zalaudek, I; Di, Meo, N.
Targetoid erythema surrounding multiple seborrheic keratoses induced by chemotherapy with gemcitabine.
Acta Dermatovenerol Alp Pannonica Adriat. 2019; 28(4): 185-186. Doi: 10.15570/actaapa.2019.44 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Zalaudek Iris
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
The cutaneous adverse effects of gemcitabine include allergic skin rash frequently associated with pruritus, alopecia, sweating, dermatitis with boils, and ulcerations. We report the case of a patient that developed inflammation of seborrheic keratoses after gemcitabine treatment.
Find related publications in this database (using NLM MeSH Indexing)
Adenocarcinoma of Lung - drug therapy
Aged - administration & dosage
Antimetabolites, Antineoplastic - adverse effects, therapeutic use
Deoxycytidine - adverse effects, analogs & derivatives, therapeutic use
Drug Eruptions - etiology
Female - administration & dosage
Humans - administration & dosage
Keratosis, Seborrheic - chemically induced

Find related publications in this database (Keywords)
gemcitabine
seborrheic keratoses
drug adverse reaction
© Med Uni GrazImprint